697491919	697491919	CD	B-NP	O
|	|	NN	I-NP	O
RGH	RGH	NN	I-NP	O
|	|	NN	I-NP	O
01258009	01258009	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2520740	2520740	CD	B-NP	O
|	|	CC	I-NP	O
6/18/2006	6/18/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Congestive	Congestive	JJ	I-NP	I-protein
heart	heart	NN	I-NP	I-protein
failure	failure	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/4/2006	11/4/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/19/2006	10/19/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
RUPPRECHT	RUPPRECHT	NN	B-NP	O
,	,	,	O	O
GLENN	GLENN	NN	B-NP	O
688-07-41-4	688-07-41-4	CD	I-NP	O
Agehousena	Agehousena	NNP	I-NP	O
Lane	Lane	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
8/12/06	8/12/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CHICHESTER	CHICHESTER	NNP	B-NP	O
,	,	,	O	O
JR	JR	NNP	B-NP	O
,	,	,	O	O
DUDLEY	DUDLEY	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
200	200	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/25/06	9/25/06	CD	B-NP	O
by	by	IN	B-PP	O
NESHEM	NESHEM	NNP	B-NP	O
,	,	,	O	O
IAN	IAN	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
877835424	877835424	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
daily	daily	JJ	B-NP	O
coags	coag	NNS	I-NP	O
checked	check	VBD	B-VP	O
ECOTRIN	ECOTRIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/25/06	9/25/06	CD	B-NP	O
by	by	IN	B-PP	O
FERULLO	FERULLO	NNP	B-NP	O
,	,	,	O	O
BRAD	BRAD	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
877835424	877835424	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
daily	daily	JJ	B-NP	O
coags	coag	NNS	I-NP	O
checked	check	VBD	B-VP	O
LIPITOR	LIPITOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/25/06	9/25/06	CD	B-NP	O
by	by	IN	B-PP	O
FRIEST	FRIEST	NNP	B-NP	O
,	,	,	O	O
BRENDAN	BRENDAN	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
877835424	877835424	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
daily	daily	JJ	B-NP	O
coags	coag	NNS	I-NP	O
checked	check	VBD	B-VP	O
COLCHICINE	COLCHICINE	NN	B-NP	O
0.6	0.6	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/7	7/7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LANTUS	LANTUS	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
GLARGINE	GLARGINE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC+HS	AC+HS	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
units	unit	NNS	B-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
400	400	CD	I-NP	O
K-DUR	K-DUR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
IL	IL	NN	B-NP	B-protein
*	*	SYM	B-NP	O
MCH	MCH	NN	I-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/1/06	6/1/06	CD	B-NP	O
by	by	IN	B-PP	O
BISIGNANO	BISIGNANO	NNP	B-NP	O
,	,	,	O	O
CHAUNCEY	CHAUNCEY	NNP	B-NP	O
O.	O.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
daily	daily	JJ	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
checked	check	VBD	B-VP	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/1/06	6/1/06	CD	B-NP	O
by	by	IN	B-PP	O
BIEL	BIEL	NNP	B-NP	O
,	,	,	O	O
CODY	CODY	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
K-DUR	K-DUR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
118275273	118275273	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
daily	daily	JJ	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
checked	check	VBD	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/17/06	3/17/06	CD	B-NP	O
by	by	IN	B-PP	O
GENTER	GENTER	NNP	B-NP	O
,	,	,	O	O
MOHAMMAD	MOHAMMAD	NNP	B-NP	O
JONATHAN	JONATHAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
392117323	392117323	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/6/06	1/6/06	CD	B-NP	O
by	by	IN	B-PP	O
MCKIMMY	MCKIMMY	NNP	B-NP	O
,	,	,	O	O
ANTONIO	ANTONIO	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
525254429	525254429	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NAFCILLIN	NAFCILLIN	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
GM	GM	NNP	I-NP	I-protein
IV	IV	CD	I-NP	I-protein
Q4H	Q4H	NN	I-NP	I-protein
OXYCODONE	OXYCODONE	NN	I-NP	I-protein
5-10	5-10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
TRAZODONE	TRAZODONE	NNP	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BEDTIME	BEDTIME	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Insomnia	Insomnia	NNP	I-NP	I-protein
COUMADIN	COUMADIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
WARFARIN	WARFARIN	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/25/06	9/25/06	CD	B-NP	O
by	by	IN	B-PP	O
MARKEL	MARKEL	NNP	B-NP	O
,	,	,	O	O
GLEN	GLEN	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
daily	daily	JJ	B-NP	O
coags	coag	NNS	I-NP	O
checked	check	VBD	B-VP	O
DIET	DIET	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Coggin	Coggin	NNP	I-NP	O
,	,	,	O	O
FH	FH	NNP	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
11/5/06	11/5/06	CD	I-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	SYM	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Pyon	Pyon	NNP	I-NP	O
,	,	,	O	O
Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
10/19/06	10/19/06	CD	I-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	SYM	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Rubin	Rubin	NNP	I-NP	O
Stefanovich	Stefanovich	NNP	I-NP	O
,	,	,	O	O
RNRMC	RNRMC	NNP	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
10/19/06	10/19/06	CD	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Lestor	Lestor	NNP	I-NP	O
,	,	,	O	O
your	your	PRP$	B-NP	O
Primary	Primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
in	in	IN	B-PP	O
2-3	2-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
3/1/06	3/1/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
tobedeterminedbyINR	tobedeterminedbyINR	NN	I-NP	O
.	.	.	O	O

days	day	NNS	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Skilled	Skille	VBN	B-NP	O
nursing	nursing	NN	I-NP	O
facility/rehab	facility/rehab	NN	I-NP	O
MD	MD	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
LINEZOLID	LINEZOLID	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Congestive	Congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
3v	3v	CD	I-NP	O
obesity	obesity	NN	I-NP	O
DM	DM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
ICD	ICD	NN	I-NP	O
reduced	reduce	VBD	B-VP	O
LVEF	LVEF	NN	B-NP	B-protein
~	~	NN	I-NP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
MRSA	MRSA	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
NONE	NONE	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NONE	NONE	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
63M	63M	NN	B-NP	O
w	w	NN	I-NP	O
h/o	h/o	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
25-30	25-30	CD	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CKD	CKD	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
baseline	baseline	NN	I-NP	I-protein
1.7-1	1.7-1	CD	I-NP	I-protein
.9	.9	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	O	O
mutiple	mutiple	JJ	B-NP	O
toe	toe	NN	I-NP	O
amputations	amputation	NNS	I-NP	O
admitted	admit	VBN	B-VP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
w	w	NN	I-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Most	Most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
invovling	invovle	VBG	B-VP	O
the	the	DT	B-NP	O
R.	R.	NNP	I-NP	O
1st	1st	CD	I-NP	O
metatarsal	metatarsal	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
abx	abx	NN	I-NP	O
and	and	CC	I-NP	O
debridement	debridement	NN	I-NP	O
and	and	CC	O	O
initiated	initiate	VBD	B-VP	O
a	a	DT	B-NP	O
8-week	8-week	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Nafcillin	Nafcillin	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
and	and	CC	I-NP	O
notes	note	NNS	I-NP	O
increasing	increase	VBG	B-VP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
and	and	CC	I-NP	O
DOE	DOE	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
early	early	JJ	B-NP	O
satiety	satiety	NN	I-NP	O
x	x	SYM	B-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

NO	NO	NN	B-NP	O
cp/palpitations	cp/palpitation	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
F/C/NS	F/C/NS	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
n/v/d	n/v/d	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
consultation	consultation	NN	B-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
cardiologists	cardiologist	NNS	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Henjes	Henjes	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
uptitrated	uptitrate	VBN	I-VP	O
his	his	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
from	from	IN	B-PP	O
20	20	CD	B-NP	O
PO	PO	NN	I-NP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

Yet	Yet	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
sx	sx	NN	B-NP	O
.	.	.	O	O

Admitted	Admit	VBN	B-VP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
notes	note	VBZ	B-VP	O
occasional	occasional	JJ	B-NP	B-protein
BRBPR	BRBPR	NN	I-NP	I-protein
when	when	WRB	B-ADVP	O
wiping	wipe	VBG	B-VP	O
-	-	HYPH	O	O
last	last	JJ	B-NP	B-protein
colonoscopy	colonoscopy	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
yr	yr	NN	I-NP	I-protein
ago	ago	RB	B-ADVP	O
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
polyps	polyp	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
PMH/PSH	PMH/PSH	NN	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

osteomyelitis	osteomyelitis	LS	B-LST	O
--	--	:	O	O
recurrent	recurrent	JJ	B-NP	O
non-healing	non-healing	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
1st	1st	JJ	I-NP	O
metatarsal	metatarsal	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
Right	Right	NNP	B-NP	O
transmetatarsal	transmetatarsal	JJ	I-NP	O
amputation	amputation	NN	I-NP	O
.	.	.	O	O

MSSA	MSSA	NN	B-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
8	8	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
STARTED	STARTED	VBD	B-VP	O
5/20	5/20	CD	B-NP	O
END	END	NN	I-NP	O
4/30	4/30	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	B-NP	O
.	.	.	O	O

DMII	DMII	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

PVD	PVD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
amputation	amputation	NN	I-NP	O
of	of	IN	B-PP	O
1st	1st	JJ	B-NP	O
and	and	CC	I-NP	O
5th	5th	JJ	I-NP	O
toes	toe	NNS	I-NP	O
of	of	IN	B-PP	O
L.foot	L.foot	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

ischemic	ischemic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
ef-25-30	ef-25-30	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

CKD	CKD	NN	B-NP	B-protein
-	-	HYPH	O	O
baseline	baseline	NN	B-NP	O
1.7-1	1.7-1	CD	I-NP	O
.9	.9	CD	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

ICD	ICD	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
implant	implant	NN	I-NP	O
5/30/04	5/30/04	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

gout	gout	IN	B-PP	O
9	9	CD	B-NP	O
.	.	.	O	O

Type	Type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

CABG	CABG	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
1988	1988	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
LIMA	LIMA	NN	I-NP	B-protein
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	B-protein
and	and	CC	I-NP	O
OM1	OM1	NN	I-NP	B-protein
occluded	occlude	VBD	B-VP	O
-RRB-	-RRB-	NN	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

R	R	NN	B-NP	O
shoulder	shoulder	NN	I-NP	O
surgery	surgery	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
Allergies	Allergy	NNS	B-NP	O
:	:	:	O	O
Linezolid	Linezolid	JJ	B-NP	O
-	-	HYPH	I-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
or	or	CC	I-NP	O
anemia	anemia	NN	I-NP	O
Cardiac	Cardiac	NNP	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
Imaging	Imaging	NN	B-NP	O
:	:	:	O	O
ECHO	ECHO	NN	B-NP	O
8/30/06	8/30/06	CD	I-NP	O
LV	LV	NN	I-NP	O
mod	mod	NN	I-NP	O
dilated	dilate	VBN	B-VP	O
,	,	,	O	O
LVF	LVF	NN	B-NP	O
mod	mod	NN	I-NP	O
to	to	TO	B-VP	O
severely	severely	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
25-30	25-30	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
LV	LV	NN	B-NP	O
is	be	VBZ	B-VP	O
akinetic/hypokinetic	akinetic/hypokinetic	JJ	B-ADJP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
LAE/RAE	LAE/RAE	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
and	and	CC	I-NP	O
TR	TR	NN	I-NP	B-protein
STRESS	STRESS	NN	I-NP	I-protein
6/7/05	6/7/05	CD	I-NP	I-protein
No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
because	because	IN	B-SBAR	O
maximal	maximal	JJ	B-NP	O
HR	HR	NN	I-NP	O
below	below	IN	B-PP	O
diagnostic	diagnostic	JJ	B-NP	O
target	target	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
<	<	SYM	O	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
max	max	NN	I-NP	O
HR	HR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Peak	Peak	JJ	B-NP	O
O2	O2	NN	I-NP	O
uptake	uptake	NN	I-NP	O
was	be	VBD	B-VP	O
above	above	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
threshold	threshold	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
Outpatient	Outpatient	NN	I-NP	O
Medications	Medication	NNS	I-NP	O
:	:	:	O	O
Medications	Medication	NNS	B-NP	O
Text	Text	IN	B-PP	O
nafcillin	nafcillin	NN	B-NP	B-protein
2g	2g	NN	I-NP	I-protein
q4	q4	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
5/7	5/7	CD	I-NP	O
Last	Last	JJ	I-NP	O
day	day	NN	I-NP	O
is	be	VBZ	B-VP	O
11/5/06	11/5/06	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
lasix	lasix	CD	I-NP	O
40mg	40mg	CD	I-NP	O
daily	daily	JJ	I-NP	O
colchicine	colchicine	NN	I-NP	O
0.6	0.6	CD	I-NP	O
qd	qd	NN	I-NP	O
iron	iron	NN	I-NP	O
325	325	CD	I-NP	O
daily	daily	JJ	I-NP	O
ASA	ASA	NN	I-NP	O
325	325	CD	I-NP	O
daily	daily	JJ	I-NP	O
lipitor	lipitor	NN	I-NP	O
80	80	CD	I-NP	O
daily	daily	JJ	I-NP	O
digoxin	digoxin	NN	I-NP	O
0.125	0.125	CD	I-NP	O
daily	daily	JJ	I-NP	O
colace	colace	NN	I-NP	O
100	100	CD	I-NP	O
bid	bid	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
12.5	12.5	CD	I-NP	O
daily	daily	JJ	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
5	5	CD	I-NP	O
daily	daily	JJ	I-NP	O
lopressor	lopressor	NN	I-NP	O
25	25	CD	I-NP	O
q6	q6	NN	I-NP	O
oxycodone	oxycodone	NN	I-NP	O
5-10	5-10	CD	I-NP	O
prn	prn	NN	I-NP	O
ibuprofen	ibuprofen	NN	I-NP	O
600	600	CD	I-NP	O
q6	q6	NN	I-NP	O
prn	prn	NN	I-NP	O
NPH	NPH	NN	I-NP	O
,	,	,	O	O
RISS	RISS	NN	B-NP	O
ferrous	ferrous	JJ	I-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
QD	QD	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
Family	Family	RB	B-NP	O
History	History	NN	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
:	:	:	O	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
DM2	DM2	NN	B-NP	O
CAD	CAD	NN	I-NP	O
:	:	:	O	O
both	both	DT	B-NP	O
parents	parent	NNS	I-NP	O
sides	side	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
HBP	HBP	NN	I-NP	O
:	:	:	O	O
father	father	NN	B-NP	O
Renal	Renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
Hyperlipidemia	Hyperlipidemia	NN	I-NP	O
:	:	:	O	O
unknown	unknown	JJ	B-ADJP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
Social	Social	JJ	B-NP	O
History	History	NN	I-NP	O
:	:	:	O	O
Currently	Currently	RB	B-NP	O
an	an	DT	I-NP	O
inpatient	inpatient	NN	I-NP	O
at	at	IN	B-PP	O
Ter	Ter	NNP	B-NP	O
's	's	POS	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
to	to	TO	B-VP	O
receive	receive	VB	I-VP	O
Nafcillin	Nafcillin	NN	B-NP	O
IV	IV	CD	I-NP	O
q4h	q4h	NN	I-NP	O
.	.	.	O	O

Previously	Previously	RB	B-ADVP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
in	in	IN	B-PP	O
Ran	Ran	NNP	B-NP	B-protein
Walks	Walks	NNP	I-NP	O
his	his	PRP$	B-NP	O
son	son	NN	I-NP	O
's	's	POS	B-NP	O
dog	dog	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
work	work	VB	I-VP	O
for	for	IN	B-PP	O
10yrs	10yr	NNS	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

Formerly	Formerly	RB	B-ADVP	O
worked	work	VBN	B-VP	O
in	in	IN	B-PP	O
sheet	sheet	NN	B-NP	O
metal	metal	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
smoking	smoking	NN	I-NP	O
.	.	.	O	O

Rare	Rare	NN	B-NP	O
EtOH	EtOH	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
IDVU	IDVU	NN	I-NP	B-protein
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
ADMIT	ADMIT	NN	I-NP	B-protein
Physical	Physical	NNP	I-NP	O
Examination	Examination	NNP	I-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
96.8	96.8	CD	B-NP	O
BP	BP	NN	I-NP	O
120/78	120/78	CD	B-NP	O
HR	HR	NN	I-NP	O
95	95	CD	B-NP	O
RR	RR	NN	I-NP	O
20	20	CD	B-NP	O
O2sat	O2sat	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

116.6	116.6	CD	B-NP	O
KG	KG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
106.4	106.4	CD	I-NP	O
Kg	Kg	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Gen	Gen	NNP	I-NP	O
:	:	:	O	O
fatigued	fatigue	VBD	B-VP	O
appearing	appear	VBG	B-NP	O
,	,	,	O	O
pleasant	pleasant	NN	B-NP	O
.	.	.	O	O

Speaking	Speak	VBG	B-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
anicteric	anicteric	JJ	B-NP	O
,	,	,	I-NP	O
conjunctivae	conjunctivae	JJ	I-NP	O
pink	pink	NN	I-NP	O
,	,	,	O	O
EOM	EOM	NN	B-NP	O
full	full	JJ	B-ADJP	O
.	.	.	O	O

MMM	MMM	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
thrush	thrush	NN	I-NP	O
,	,	,	O	O
Neck	Neck	NNP	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
to	to	TO	B-VP	O
angle	angle	VB	I-VP	O
jaw	jaw	NN	B-NP	O
at	at	IN	B-PP	O
90	90	CD	B-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
Lymphadenopathy	Lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
:	:	:	O	O
PA	PA	NN	B-NP	B-protein
tap	tap	NN	I-NP	I-protein
,	,	,	O	O
RV	RV	NN	B-NP	O
heave	heave	NN	I-NP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
III/VI	III/VI	CD	B-NP	O
holosystolic	holosystolic	JJ	I-NP	O
musical	musical	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
throughout	throughout	IN	B-PP	O
precordium	precordium	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
S3/S4	S3/S4	NN	I-NP	B-protein
or	or	CC	I-NP	O
rubs	rub	NNS	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
Fine	Fine	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
right	right	JJ	B-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

o/w	o/w	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
.	.	.	O	O

Abd	Abd	NN	B-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
NT/ND	NT/ND	NN	I-NP	B-protein
,	,	,	O	O
+	+	SYM	B-NP	O
BS	BS	NNP	B-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
shifting	shift	VBG	I-NP	O
dullness	dullness	NN	I-NP	O
.	.	.	O	O

Ext	Ext	NN	B-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-VP	O
above	above	VB	I-VP	O
knee	knee	NN	B-NP	O
.	.	.	O	O

Right	Right	NN	B-NP	O
foot	foot	NN	I-NP	O
bandaged	bandage	VBN	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
open	open	JJ	I-NP	O
wounds	wound	NNS	I-NP	O
L.	L.	NNP	I-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

L	L	NN	B-NP	O
foot	foot	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
hair	hair	NN	I-NP	O
,	,	,	O	O
taught	taught	NN	B-NP	O
skin	skin	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
skin	skin	NN	I-NP	O
breakdown	breakdown	NN	I-NP	O
R	R	NN	I-NP	O
foot	foot	NN	I-NP	O
:	:	:	O	O
deep	deep	JJ	B-NP	O
clean	clean	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
wound	wound	NN	I-NP	O
at	at	IN	B-PP	O
midpoint	midpoint	NN	B-NP	O
of	of	IN	B-PP	O
TMA	TMA	NN	B-NP	B-protein
,	,	,	O	O
wound	wind	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
bone	bone	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
surrounding	surround	VBG	I-NP	O
erythema	erythema	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

Healthy	Healthy	JJ	B-NP	O
appearing	appear	VBG	I-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
DATA	DATA	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
Na	Na	NN	B-NP	B-protein
143	143	CD	I-NP	I-protein
.	.	.	O	O

K	K	NN	B-NP	O
4.3	4.3	NN	I-NP	O
.	.	.	O	O

BUN	BUN	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
2.1	2.1	CD	I-NP	O
.	.	.	O	O

WBC	WBC	NN	B-NP	B-DNA
7.6	7.6	CD	I-NP	I-DNA
HCT	HCT	NN	I-NP	I-DNA
32.8	32.8	CD	B-NP	I-DNA
,	,	,	O	O
PLTS	PLTS	NNP	B-NP	B-cell_line
254	254	CD	I-NP	I-cell_line
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.2	0.2	CD	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
711	711	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
186	186	CD	B-NP	O
on	on	IN	B-PP	O
2/23/06	2/23/06	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
Status/Events	Status/Event	NNS	I-NP	O
-LRB-	-LRB-	SYM	O	O
5/25	5/25	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
Feeling	Feeling	NN	B-NP	O
better	better	RB	B-ADVP	O
and	and	CC	I-ADVP	O
back	back	RB	I-ADVP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
respiratory	respiratory	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Tmax	Tmax	NN	B-NP	B-protein
98.4	98.4	CD	I-NP	I-protein
,	,	,	O	O
Tc	Tc	NN	B-NP	B-protein
96.1	96.1	CD	I-NP	I-protein
,	,	,	O	O
P70-92	P70-92	NN	B-NP	B-protein
.	.	.	O	O

BP	BP	NN	B-NP	O
110-120/60	110-120/60	CD	I-NP	O
-80	-80	CD	I-NP	O
,	,	,	I-NP	O
02	02	CD	I-NP	O
sat	sit	VBD	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
.	.	.	O	O

Diuresing	Diurese	VBG	B-VP	O
well	well	RB	B-NP	O
JVP	JVP	NN	I-NP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
fine	fine	JJ	I-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
on	on	IN	B-PP	O
inspiration	inspiration	NN	B-NP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
.	.	.	O	O

3/6	3/6	CD	B-NP	O
MR	MR	NN	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
+	+	SYM	I-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
below	below	IN	B-PP	O
knees	knee	NNS	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
2/1	2/1	CD	B-NP	O
NA	NA	NN	I-NP	O
139	139	CD	B-NP	O
,	,	,	O	O
K	K	NN	B-NP	B-cell_line
4.3	4.3	NN	I-NP	I-cell_line
,	,	,	O	O
Cl	Cl	NN	B-NP	B-protein
103	103	CD	I-NP	I-protein
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
26	26	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NNP	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
1.9	1.9	CD	I-NP	O
.	.	.	O	O

Mg	Mg	NN	B-NP	O
2.4	2.4	CD	I-NP	O
WBC	WBC	NNP	I-NP	O
6.4	6.4	CD	I-NP	O
HCT	HCT	NN	I-NP	O
32.3	32.3	CD	I-NP	O
,	,	,	O	O
PLTS	PLTS	NNP	B-NP	B-cell_line
217	217	CD	I-NP	I-cell_line
.	.	.	O	O

INR	INR	NN	B-NP	O
2.2	2.2	CD	I-NP	O
PTT	PTT	NN	I-NP	O
41.5	41.5	CD	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
A/P	A/P	NN	B-NP	O
:	:	:	O	O
63M	63M	NN	B-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
iCMP	iCMP	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
EF	EF	NN	I-NP	I-protein
25-30	25-30	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
ICD	ICD	NN	B-NP	B-protein
,	,	,	O	O
placed	place	VBN	B-VP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
LE	LE	NNP	B-NP	O
edema	edema	NNP	I-NP	O
,	,	,	O	O
PND	PND	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NYHA	NYHA	NNP	I-NP	O
III	III	NNP	I-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

CV	CV	NN	B-NP	O
:	:	:	O	O
i	i	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
,	,	,	O	O
Ace-i	Ace-i	NNP	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
Cr	Cr	NNP	I-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
elevated	elevate	VBN	B-VP	O
2.2	2.2	CD	B-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	B-protein
1.7-1	1.7-1	CD	I-NP	I-protein
.9	.9	CD	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
instead	instead	RB	B-CONJP	O
of	of	IN	I-CONJP	O
Metoprolol	Metoprolol	NN	B-NP	O
25	25	CD	I-NP	O
QID	QID	NN	I-NP	O
.	.	.	O	O

p	p	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
22	22	CD	B-NP	O
lbs	lb	NNS	I-NP	O
over	over	IN	B-PP	O
dry	dry	JJ	B-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	O	O
He	He	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
IV	IV	CD	I-NP	O
BID	BID	NN	I-NP	O
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.9-2	1.9-2	CD	B-NP	O
.0	.0	CD	I-NP	O
and	and	CC	O	O
average	average	NN	B-NP	O
of	of	IN	B-PP	O
2-2	2-2	JJ	B-NP	O
.2	.2	NN	I-NP	O
L	L	NN	I-NP	O
net	net	JJ	I-NP	O
negative	negative	JJ	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

Symptoms	Symptom	NNS	B-NP	O
improved	improve	VBD	B-VP	O
dramatically	dramatically	RB	B-ADVP	O
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
and	and	CC	I-NP	O
shotness	shotness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

O2	O2	NN	B-NP	O
sats	sat	NNS	I-NP	O
were	be	VBD	B-VP	O
98-99	98-99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
stable	stable	JJ	B-ADJP	O
without	without	IN	B-PP	O
additional	additional	JJ	B-NP	O
repletion	repletion	NN	I-NP	O
on	on	IN	B-PP	O
standing	stand	VBG	B-VP	O
KDur	KDur	NNP	B-NP	O
.	.	.	O	O

-	-	HYPH	O	O
He	He	PRP	B-NP	B-DNA
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

r	r	NN	B-NP	O
:	:	:	O	O
Sinus	Sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Nonspecific	Nonspecific	JJ	B-NP	O
IVCD	IVCD	NN	I-NP	O
.	.	.	O	O

Monitored	Monitor	VBN	B-VP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
without	without	IN	B-PP	O
events	event	NNS	B-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
DM	DM	NN	B-NP	O
-	-	HYPH	B-NP	O
Regular	Regular	JJ	I-NP	O
ISS	ISS	NN	I-NP	O
.	.	.	O	O

Added	Add	VBN	B-VP	O
basal	basal	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
SC	SC	NN	I-NP	O
QD	QD	NN	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
as	as	IN	B-PP	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
was	be	VBD	B-VP	O
running	run	VBG	I-VP	O
180-220	180-220	CD	B-NP	O
prior	prior	JJ	I-NP	O
to	to	TO	B-PP	O
meals	meal	NNS	B-NP	O
and	and	CC	O	O
requiring	require	VBG	B-VP	O
average	average	NN	B-NP	O
of	of	IN	B-PP	O
4-5	4-5	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Continued	Continued	NNP	B-NP	O
Nafcillin	Nafcillin	NNP	I-NP	O
2g	2g	NN	I-NP	O
IV	IV	CD	I-NP	O
q4h	q4h	NN	I-NP	O
for	for	IN	B-PP	O
r.	r.	NN	B-NP	O
foot	foot	NN	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
.	.	.	O	O

Seen	Seen	NN	B-NP	O
by	by	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
consult	consult	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
for	for	IN	B-PP	O
advice	advice	NN	B-NP	O
on	on	IN	B-PP	O
wound	wound	NN	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
BID	BID	VBN	I-VP	O
dressing	dress	VBG	I-VP	O
changes	change	NNS	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
had	have	VBD	B-VP	O
granulation	granulation	NN	B-NP	O
tissue	tissue	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
surrounding	surround	VBG	I-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Continue	Continue	NNP	I-NP	O
wound	wound	NN	I-NP	O
care	care	NN	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
vascular	vascular	JJ	B-NP	B-cell_type
surgery	surgery	NN	I-NP	I-cell_type
recs	rec	NNS	I-NP	I-cell_type
:	:	:	O	O
-	-	HYPH	O	O
No	No	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
debridgement	debridgement	NN	B-NP	O
.	.	.	O	O

Wet	Wet	NN	B-NP	O
to	to	TO	B-PP	O
dry	dry	JJ	B-NP	O
dressings	dressing	NNS	I-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
followup	followup	NN	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
dr.	dr.	NNP	B-NP	O
Defonce	Defonce	NNP	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
Vascular	Vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
-	-	HYPH	B-NP	O
Continued	Continue	VBN	B-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
low	low	JJ	I-NP	I-protein
EF	EF	NN	I-NP	I-protein
.	.	.	O	O

h/o	h/o	NN	B-NP	O
LV	LV	NN	I-NP	O
thrombus	thrombus	NN	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
2.0-2	2.0-2	CD	B-NP	O
.2	.2	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
.	.	.	O	O

PROPH	PROPH	NN	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Anticoagulation	Anticoagulation	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
indication	indication	NN	I-NP	O
for	for	IN	B-PP	O
PPI	PPI	NN	B-NP	B-protein
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

2L	2L	NN	B-NP	O
fluid	fluid	NN	I-NP	O
restrict	restrict	NN	I-NP	O
.	.	.	O	O

ACCESS	ACCESS	NN	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Right	Right	NN	I-NP	O
upper	upper	JJ	I-NP	O
arm	arm	NN	I-NP	O
PICC	PICC	NN	I-NP	O
.	.	.	O	O

Full	Full	NNP	B-NP	O
Code	Code	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNPS	I-NP	O
:	:	:	O	O
-	-	HYPH	O	O
You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
on	on	IN	B-PP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

-	-	HYPH	O	O
There	There	EX	B-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
changes	change	NNS	I-NP	O
made	make	VBN	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Allopurinol	Allopurinol	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
-LRB-	-LRB-	IN	B-PP	O
a	a	DT	B-NP	O
medication	medication	NN	I-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
prevent	prevent	VB	I-VP	O
gout	gout	NN	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

2	2	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
does	do	VBZ	B-VP	O
is	be	VBZ	B-VP	O
80mg	80mg	NN	B-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Followup	Followup	NN	I-NP	O
appointments	appointment	NNS	I-NP	O
are	be	VBP	B-VP	O
listed	list	VBN	I-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
PETRELLI	PETRELLI	NNP	B-NP	O
,	,	,	O	O
KIP	KIP	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DQ060	DQ060	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/12/06	8/12/06	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

